U-Neuron Biomedical (ROCO:6973) EBITDA Margin % : -168.13% (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is U-Neuron Biomedical EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. U-Neuron Biomedical's EBITDA for the six months ended in Dec. 2023 was NT$-25.26 Mil. U-Neuron Biomedical's Revenue for the six months ended in Dec. 2023 was NT$15.02 Mil. Therefore, U-Neuron Biomedical's EBITDA margin for the quarter that ended in Dec. 2023 was -168.13%.

U-Neuron Biomedical EBITDA Margin % Historical Data

The historical data trend for U-Neuron Biomedical's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

U-Neuron Biomedical EBITDA Margin % Chart

U-Neuron Biomedical Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

EBITDA Margin %

-33.84

-136.35

-288.17

U-Neuron Biomedical Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23
EBITDA Margin %	-	-90.67	-196.69	-438.46	-168.13

Competitive Comparison of U-Neuron Biomedical's EBITDA Margin %

For the Biotechnology subindustry, U-Neuron Biomedical's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

U-Neuron Biomedical's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, U-Neuron Biomedical's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where U-Neuron Biomedical's EBITDA Margin % falls into.

U-Neuron Biomedical EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

U-Neuron Biomedical's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-77.873	/	27.023
	=	-288.17 %

U-Neuron Biomedical's EBITDA Margin % for the quarter that ended in Dec. 2023 is calculated as

EBITDA Margin %	=	EBITDA (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-25.258	/	15.023
	=	-168.13 %

U-Neuron Biomedical (ROCO:6973) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

U-Neuron Biomedical EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of U-Neuron Biomedical's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

U-Neuron Biomedical (ROCO:6973) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » U-Neuron Biomedical Inc (ROCO:6973) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

https://en.u-neuron.com

U-Neuron Biomedical Inc is engaged in research and development of stem cell storage & separation technology, and treatment application technology. It has patent on the Technology of Culture and Isolation of Amniotic Fluid Stem Cell.

U-Neuron Biomedical (ROCO:6973) Headlines

No Headlines